BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 26, 2006
View Archived Issues
BT-11: procognitive dietary supplement for SMI or MCI
Read More
F-15599: new 5-HT1A targeting antidepressant candidate
Read More
Preclinical characterization and pharmacokinetics of the novel DPP-IV inhibitor GRC-8011
Read More
Preclinical and clinical antidiabetic and antiobesity efficacy of the GLP-1 analogue liraglutide
Read More
Baraclude launched in Japan
Read More
Japanese launch for Cetrotide for use in IVF
Read More
Pivotal results for icatibant in hereditary angioedema
Read More
Itax development discontinued in functional dyspepsia and diabetic gastropathy
Read More
Tarceva studied as adjuvant treatment in NSCLC
Read More
Inex shareholders approve spin-out of Tekmira
Read More
European orphan drug designation for Debio-0513 in myasthenia gravis
Read More
AT-1001 studied in phase II trial for celiac disease
Read More
Development of TZP-101 extended to include patients with gastroparesis
Read More
Dimebon meets all five efficacy endpoints in Alzheimer's study
Read More
EVT-201 studied in phase II insomnia trial
Read More
German clearance for phase IIb/III study of BF-200 ALA
Read More
Inhaled powder formulation of Ostabolin-C studied in phase I trial
Read More
Novel antiinfective agents disclosed in recent patent literature
Read More
Novel oncolytic drugs revealed in recent patents
Read More
Novel 5-HT4 receptor agonists for gastrointestinal disorders emerge from Pfizer R&D
Read More
R&D highlights from the UBS Global Life Sciences Conference in New York: Cipher Pharmaceuticals
Read More
Approvable letter for Factive in five-day treatment of CAP
Read More
Gardasil approved in E.U.
Read More
Fentora approved for management of cancer breakthrough pain
Read More
Taxotere recommended for approval in Europe for head and neck cancer
Read More
Lamictal approved for new epilepsy indication
Read More
Merck & Co. reports on new bradykinin B1 receptor antagonists
Read More
New apoptosis inducers developed at Advanced Life Sciences
Read More
3M Pharmaceuticals reveals new TLR7 receptor agonist
Read More
Improved oral bioavailability with HepDirect nucleoside prodrugs for the treatment of HCV infection
Read More
